Sort
82,697 grants matching “vaccine development”
Development and Production of SARS-CoV2 Biologicals and Vaccines
$4,391,926Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2022 · AI
Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats
$4,390,495Kartik Chandran · Albert Einstein College Of Medicine · U19 · FY2021 · AI
Chemoprophylaxis for HIV Prevention in Men
$4,388,511Robert M. Grant · J. David Gladstone Institutes · U01 · FY2011 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$4,384,228Judith S. Currier · University Of California Los Angeles · UM1 · FY2022 · AI
Safeguard the household: comprehensive AIDS research
$4,381,107Wits Health Consortium (Pty), Ltd · U19 · FY2003 · AI
Northern New England Clinical and Translational Research Network
$4,373,893Clifford J Rosen · Mainehealth · U54 · FY2024 · GM
Einstein-Montefiore Clinical and Translational Science Award Hub
$4,368,000Marla J Keller · Albert Einstein College Of Medicine · UM1 · FY2023 · TR
HIV Vaccine Trials Network Laboratory Center
$4,367,621Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2022 · AI
Arming the Immune System Against Pathogens
$4,365,288Harvard University (Sch Of Public Hlth) · P01 · FY2005 · AI
Harnessing Human DC Subsets for Improved Muscosal Vaccines
$4,362,911Gerard Zurawski · Baylor Research Institute · U19 · FY2013 · AI
Center for Immunological Interventions against Gonorrhea (CIIG)
$4,362,124Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2025 · AI
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
$4,360,341Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2022 · AI
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
$4,359,363Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2018 · AI
Boston HIV CTU
$4,358,930Daniel R Kuritzkes · Brigham And Women'S Hospital · UM1 · FY2021 · AI
Einstein-Montefiore Clinical and Translational Science Award Hub
$4,357,992Jessica A Kahn · Albert Einstein College Of Medicine · UM1 · FY2024 · TR
Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats
$4,357,599Kartik Chandran · Albert Einstein College Of Medicine · U19 · FY2022 · AI
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.
$4,353,842Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2021 · CA
GM-CSF-Adjuvanted Clade C DNA/MVA and MVA/MVA Vaccines
$4,352,253Harriet L Robinson · Geovax, Inc. · U19 · FY2011 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core
$4,351,463Wendell Beres · Duke University · N01 · FY2025 · AI
Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats
$4,348,829Kartik Chandran · Albert Einstein College Of Medicine · U19 · FY2019 · AI
Task 18 (D24): EFFICACY TESTING OF THERAPEUTICS AGAINST ANTHRAX IN NHP
$4,342,262Lovelace Biomedical & Environmental Research Institute · N01 · FY2009 · AI
Boston HIV CTU
$4,338,234Daniel R Kuritzkes · Brigham And Women'S Hospital · UM1 · FY2023 · AI
Center for AIDS Research
$4,338,043David Mitchell Smith · University Of California, San Diego · P30 · FY2020 · AI
IND-enabling program for a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder
$4,336,347Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2023 · DA
Task 15/C30: SMALL ANIMAL MODELS FOR SARS
$4,331,787Judy Britt · Southern Research Institute · N01 · FY2009 · AI